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Abstract The most frequently used and the best estab-
lished method of biological dosimetry at present is the
dicentric chromosome assay, which is poorly suitable for a
mass casualties scenario. This gives rise to the need for the
development of new, high-throughput assays for rapid
identification of the subjects exposed to ionizing radiation.
In the present study, we tested the usefulness of gene ex-
pression analysis in blood cells for biological dosimetry.
Human peripheral blood from three healthy donors was
X-irradiated with doses of 0 (control), 0.6, and 2 Gy. The
mRNA level of 16 genes (ATF3, BAX, BBC3, BCL2,
CDKN1A, DDB2, FDXR, GADD45A, GDF15, MDM2,
PLK3, SERPINE1, SESN2, TNFRSF10B, TNFSF4, and
VWCE) was assessed by reverse transcription quantitative
PCR 6, 12, 24, and 48 h after exposure with ITFG1 and
DPM1 used as a reference genes. The panel of radiation-
responsive genes was selected comprising GADD45A,
CDKN1A, BAX, BBC3, DDB2, TNFSF4, GDF15, and
FDXR. Cluster analysis showed that DCt values of the se-
lected genes contained sufficient information to allow
discrimination between irradiated and non-irradiated blood
samples. The samples were clearly grouped according to
the absorbed doses of radiation and not to the time interval
after irradiation or to the blood donor.
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Introduction
Biological dosimetry is the quantification of exposure to
ionizing radiation by means of measurable biological
changes (biological indicators) that take place in the bio-
logical system. Based on such indicators, cases of indi-
vidual exposure to ionizing radiation can be detected and
possible consequences of the exposure predicted. This en-
ables the planning of adequate medical treatment, when
information from physical dosimetry is not available
(Stephan et al. 2007).
Currently, the most frequently used and the best estab-
lished method of biological dosimetry is the dicentric
chromosome assay (DCA). It has many advantages, such as
high specificity for ionizing radiation and low background
in the healthy general population (about 1–2 dicentrics per
1000 cells) (Pinto et al. 2010). Although dicentric chro-
mosomes are unstable and cells bearing such aberrations
are eliminated from the circulating lymphocyte pool, the
frequency of dicentrics decreases quite slowly with time
and reliable dosimetry may be performed even months
after irradiation. Another advantage of DCA is that the
aberrations are detected in peripheral blood lymphocytes
and therefore sampling is low-invasive. Also, since lym-
phocytes circulate throughout the organism, dosimetry is
possible even when only a part of the body was irradiated.
(Sullivan et al. 2013).
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However, the DCA also has its drawbacks, the most
serious being the fact that it is time consuming and labo-
rious, and therefore poorly suitable for mass casualty sce-
narios: To reveal dicentrics, lymphocytes must be induced
to division and cultivated for 48 h before scoring can begin
(Sullivan et al. 2013). Moreover, the method requires
highly trained and experienced personnel and is therefore
difficult to automate. This, together with the time-con-
suming procedures, results in low throughput. In 2010, the
total capacity of biological dosimetry laboratories in the
European Union for DCA was 1493 samples in the triage
mode (50 metaphases per donor) and 187 samples in the
full mode (500 metaphases per donor) per week, excluding
the time needed for lymphocyte culturing (Wojcik et al.
2010). This would be insufficient in the case of a large
radiological accident involving thousands of potentially
irradiated subjects. In such a situation, the precision of
individual dose estimate is less important. An approximate
dose estimation or the identification of subjects exposed
above or below a given threshold dose would be sufficient
to support physicians in providing optimal medical assis-
tance to victims. New assays allowing for rapid identifi-
cation of exposed subjects are therefore required. Several
candidates for new biological dosimetry methods have
been proposed, including premature chromosome conden-
sation assay (PCC) (Lindholm et al. 2010), c-H2AX foci
assay (Rothkamm and Horn 2009), electron paramagnetic
resonance (EPR)-based assays (Swartz et al. 2007), and
methods based on protein or metabolic biomarkers (Coy
et al. 2011; Leszczynski 2014). One of the most encour-
aging new biodosimetry methods is the analysis of gene
expression in blood cells at the mRNA level (Amundson
et al. 2004; Badie et al. 2013; Chaudhry et al. 2012; Joiner
et al. 2011; Kabacik et al. 2011a; Tucker et al. 2012).
Several ionizing radiation-responsive genes have been
identified, and different methodological approaches have
been proposed involving either microarrays or quantitative
PCR (qPCR) (Amundson et al. 2000; Boldt et al. 2012;
Dressman et al. 2007; Fachin et al. 2007). Although this
new approach to biological dosimetry is promising, a
considerable amount of work still has to be done to com-
plete validation of the new transcriptional biomarkers over
the range of possible exposure scenarios. These include
investigating the response after different types and doses of
radiation, while also taking into consideration the different
time intervals since exposure, in order to establish a time
window in which reliable dosimetry based on gene ex-
pression analysis might be performed.
In the present work, we selected a new panel of ra-
diation-responsive genes and we demonstrated that the
analysis of expression of the selected genes allowed for the
identification of irradiated blood samples even 48 h after
exposure.
Materials and methods
Blood collection and irradiation
Blood samples were collected from three healthy volun-
teers (one male, two female) with informed consent from
all subjects. A total of 15 mL of blood was collected from
each donor in S-Monovette lithium heparin tubes (Sarst-
edt). Each sample was aliquoted into three tubes (5 mL
each) and exposed to 0, 0.6, or 2 Gy of X-rays. X-irra-
diation was carried out at 37 C, with the use of a
Smart200 (Yxlon) X-ray defectoscope operating at 200 kV
and 4.5 mA, with 3-mm Al filtration, at a dose rate of
1.14 Gy/min. Following irradiation, every tube of blood
was divided into four tubes (1 mL of the whole blood per
tube), one tube for each time point. RPMI 1640 medium
(Sigma) supplemented with 10 % fetal calf serum, 100
units/ml penicillin, and 100 lg/ml streptomycin was added
to each tube at a 2:1 ratio to the whole blood. The samples
were incubated at 37 C in a humidified incubator with
5 % CO2 for either 6, 12, 24 or 48 h. After incubation, the
samples were centrifuged at 1600 rcf for 10 min. A two mL
portion of the supernatant was discarded, and the rest of the
sample was flash-frozen in liquid nitrogen and then stored
at -75 C until RNA extraction. The schematic represen-
tation of the experiment is shown in Fig. 1.
RNA extraction and analysis of gene expression
by qPCR
Total RNA was extracted from blood samples using the
RiboPure-Blood Kit (Ambion) according to the manufac-
turer’s protocol including DNase I treatment of the eluted
RNA. To assess the concentration and purity of the RNA,
a portion of every RNA sample was diluted in TE buffer
(pH 8.0) and the absorbance at 230, 260, and 280 nm was
measured using Cary 50 UV–Vis spectrophotometer
(Varian). All RNA samples used in the subsequent ana-
lysis had a concentration over 50 ng/lL, as well as A260/
A280 and A260/A230 ratios over 2.0. RNA integrity was
tested by agarose gel electrophoresis. Five hundred
nanograms of RNA was converted to cDNA in a 20 lL
reaction volume using the High-Capacity cDNA Reverse
Transcription Kit (Life Technologies) following the
manufacturer’s instructions. After completing the reaction,
cDNA was diluted to 200 lL with deionized, nuclease-
free H2O. Subsequently, qPCR was performed in a 20-lL
reaction mixture containing 4 lL of the diluted cDNA,
5 lL of deionized, nuclease-free H2O, 10 lL of TaqMan
Gene Expression Master Mix (Life Technologies), and
1 lL of TaqMan Gene Expression Assay (Life Tech-
nologies). The IDs of the TaqMan assays used in the study
are given in Table 1. All reactions were run in duplicate.





Table 1 TaqMan gene expression assays used in the study
Gene symbol Assay ID (Life Technologies) Context sequence Amplicon length (bp)
ACTB Hs99999903_m1 TCGCCTTTGCCGATCCGCCGCCCGT 171
ATF3 Hs00231069_m1 CACAAAAGCCGAGGTAGCCCCTGAA 108
BAX Hs00180269_m1 CTGGTGCTCAAGGCCCTGTGCACCA 62
BBC3 Hs00248075_m1 GAGCGGCGGAGACAAGAGGAGCAGC 101
BCL2 Hs00608023_m1 CGGAGGCTGGGATGCCTTTGTGGAA 81
CDKN1A Hs00355782_m1 GCAGACCAGCATGACAGATTTCTAC 66
DDB2 Hs03044953_m1 GCCTCTGCAATGGGTTACCACATTC 88
DPM1 Hs00187270_m1 AGTTGGGACTAGGAACTGCATATAT 100
FDXR Hs00244586_m1 ACCTGCTAAAGCACCCCCAGGCCCA 71
GADD45A Hs00169255_m1 CGTGCTGGTGACGAATCCACATTCA 123
GAPDH Hs99999905_m1 TTGGGCGCCTGGTCACCAGGGCTGC 122
GDF15 Hs00171132_m1 CGCCAGAAGTGCGGCTGGGATCCGG 78
HPRT1 Hs01003267_m1 GCAGCCCTGGCGTCGTGATTAGTGA 72
ITFG1 Hs00229263_m1 GGAAAATTTGGATGGAAACTTCTCT 102
MDM2 Hs00234753_m1 GTGAGGAGCAGGCAAATGTGCAATA 86
PLK3 Hs00177725_m1 GAGGAAGAAGACCATCTGTGGCACC 77
SERPINE1 Hs01126607_g1 CAACCCCACAGGAACAGTCCTTTTC 71
SESN2 Hs00230241_m1 CGTGGAGGAGGTCCTTCGGGAGGGG 65
TNFRSF10B Hs00366278_m1 TCCCACTGAGACTCTGAGACAGTGC 62
TNFSF4 Hs00182411_m1 TCTCTGCTCTTCAGGTATCACATCG 72
VWCE Hs00328069_m1 ATCTGCCTGCTGGGCTCAGTGGCCT 94
The ‘‘context sequence’’ is the nucleotide sequence surrounding the region to which the probe binds
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PCR amplification was carried out using a 7500 Real-
Time PCR System (Life Technologies) with an initial
10-min denaturation step at 95 C, followed by 40 cycles
of 95 C for 15 s and 60 C for 1 min. Relative fold
changes in expression were calculated using the DDCt
method with ITFG1 and DPM1 as reference controls.
Statistical analysis
A statistical analysis of the obtained data was performed
using Statistica 9.0 software (StatSoft). Statistical sig-
nificance was evaluated by an analysis of variance
(ANOVA) followed by a post hoc Tukey’s test. Differences
were considered statistically significant when the p value
was \0.05. Cluster analysis was performed using city-
block (Manhattan) distances and the unweighted pair-group
method using arithmetic averages.
Results
Selection of genes used as reference controls
The experiment was performed as outlined in Fig. 1 and
described in the Materials and methods section. Blood from
three healthy donors was X-irradiated with a dose of 0, 0.6,
or 2 Gy, and RNA was extracted after 6, 12, 24, or 48 h
after irradiation. Gene expression was measured by reverse
transcription quantitative PCR (RT-qPCR) method in
which cDNA is amplified and simultaneously detected
using fluorescent dyes or probes. The cycle number at
which the fluorescence reaches the defined threshold is
called the threshold cycle (Ct) or quantification cycle (Cq)
and is used for the quantification of the starting amount of
cDNA. To normalize for variation in the amount and
quality of RNA between different samples, the expression
of a target gene is normalized to one or more reference
genes, for which the expression is stable at the given ex-
perimental conditions. To this end, the Ct value of the
reference gene is subtracted from the Ct value of the target
gene. The resulting parameter is called DCt (Schefe et al.
2006).
Among genes, where expression is considered as a
suitable reference control for gene expression-based bio-
logical dosimetry, the most frequently used are ACTB,
GAPDH, HPRT1, and 18S rRNA (Amundson et al. 2004;
Boldt et al. 2012; Budworth et al. 2012; Chauhan et al.
2014; Chi et al. 2013; Fachin et al. 2007; Hyduke et al.
2013; Kabacik et al. 2011a; Manning et al. 2013; Paul and
Amundson 2008, 2011; Paul et al. 2013; Riecke et al. 2012;
Sudprasert et al. 2006). These genes are also the most
often used reference genes in general. Other reference
genes were also proposed based on the stability of their
expression after irradiation, e.g., DPM1, ITFG1, ERP44,
RPS9 (Filiano et al. 2011; Joiner et al. 2011; Tucker et al.
2012, 2014).
In the present work, we compared the variability of
expression of five potential reference genes (ACTB,
GAPDH, HPRT1, DPM1, and ITFG1). Statistical evalua-
tion by ANOVA showed that X-irradiation did not influ-
ence the expression of any gene under study (data not
shown). Nevertheless, the standard deviations and vari-
ances of Ct values for ITFG1 and DPM1 were much lower
than for ACTB, GAPDH, and HPRT1 (Table 2). Therefore,
in the subsequent analyses, the Ct values of target genes
were normalized to the geometric mean of Ct values for
ITFG1 and DPM1 according to the following formula:
DCt target geneð Þ ¼ Ct target geneð Þ

ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
Ct ITFG1ð Þ  Ct DPM1ð Þ
p
Expression of potential transcriptional
biodosimeters
We selected 16 genes, the expression of which was pre-
viously reported to be up- or down-regulated in blood cells
in response to ionizing radiation: ATF3, BAX, BBC3,
BCL2, CDKN1A, DDB2, FDXR, GADD45A, GDF15,
MDM2, PLK3, SERPINE1, SESN2, TNFRSF10B, TNFSF4,
and VWCE (Amundson et al. 2003; Boldt et al. 2012;
Budworth et al. 2012; Filiano et al. 2011; Grace and
Blakely 2007; Kabacik et al. 2011a, b; Li et al. 2011;
Riecke et al. 2012; Tucker et al. 2014). Expression of these
genes was analyzed by RT-qPCR at 6, 12, 24, and 48 h
after X-irradiation with the dose of 0, 0.6, or 2 Gy. The DCt
values for each gene were analyzed by two-way ANOVA
with the following factors taken into consideration: ra-
diation dose (three levels: 0, 0.6, 2 Gy), time after irra-
diation (four levels: 6, 12, 24, 48 h). The detailed results of
ANOVA for each gene are presented in Supplementary
Table 1. Both factors had a statistically significant impact
on mRNA level of the following genes: GADD45A,
CDKN1A, MDM2, SESN2, BAX, DDB2, ATF3, PLK3,
GDF15, TNFSF4, TNFRSF10B. The expression of these
genes increased with dose and decreased with time. For
BBC3 and FDXR, only the radiation dose had a significant
impact on their expression, which increased with dose. In
the case of BCL2, SERPINE1, and VWCE, only the time
factor had a significant impact on the mRNA level (the
expression decreased with time). There was no significant
interaction between the dose and time factors for any of the
genes under study. In Figs. 2 and 3, mean DCt values for
each gene are shown and dose-related differences sig-
nificant in post hoc Tukey’s test are marked. It is note-
worthy that only for TNFSF4, a significant difference
356 Radiat Environ Biophys (2015) 54:353–363
123
between doses of 0.6 and 2 Gy has been observed. Mean
fold change values for each gene are given in Table 3.
For the subsequent analysis, we selected genes for which
at least twofold changes in expression were observed for all
time points for at least one dose tested. Eight genes met the
criteria: GADD45A, CDKN1A, BBC3, BAX, DDB2,
GDF15, TNFSF4, and FDXR.
Cluster analysis
To check whether the DCt values of the selected panel of
genes give sufficient information to differentiate between
the irradiated and non-irradiated samples and between
different doses of radiation, we performed cluster analysis
resulting in the tree diagram presented in Fig. 4. In the
diagram, two main clusters can be seen, the first one con-
taining the non-irradiated samples and the second one
containing the irradiated samples. Inside the first cluster,
two smaller clusters were formed, composed of the samples
analyzed 6 and 12 h after irradiation or 24 and 48 h after
irradiation. The irradiated samples from all time points
form a distinct cluster that includes two minor clusters: one
consisting of samples irradiated with 2 Gy and the other
consisting of samples irradiated with 0.6 Gy (and one
misclassified 2 Gy sample). As can be seen, the informa-
tion from the DCt values of the selected genes was suffi-
cient to distinguish between the irradiated and non-
irradiated samples. The samples were clearly grouped ac-
cording to the absorbed doses of radiation but not to the
time interval since irradiation nor to the blood donor.
Discussion
In the majority of qPCR experiments, the mRNA level of
the target gene is quantified in relation to the mRNA level
of one or more reference genes. Thus, the appropriate
choice of reference gene(s) is important to minimize var-
iation and obtain reliable results. In our experimental setup,
the commonly used reference genes, such as ACTB,
GAPDH, or HPRT1, were not the best choice for the
analysis of gene expression in blood cells in response to
ionizing radiation. Genes ITFG1 and DPM1 previously
used by Tucker et al. (2012; 2014) and Joiner et al. (2011)
showed a lower variability in expression than ACTB,
GAPDH, and HPRT1 and therefore were used for nor-
malization in our study. A very interesting approach to the
problem of normalization of mRNA level was proposed by
Forrester and Sprung (2014), who normalized the mRNA
level of radiation-modulated transcripts to the level of ra-
diation-independent transcripts from the same gene.
Although this innovative approach is potentially very
useful, more work is needed to characterize and validate
the radiation-dependent and radiation-independent tran-
scripts for each gene of interest.
Many analyses concerning the usefulness of gene ex-
pression data for biological dosimetry purposes are based
on the fold change in expression between irradiated and
non-irradiated samples (Boldt et al. 2012; El-Saghire et al.
2013; Filiano et al. 2011; Kabacik et al. 2011a; Riecke et al.
2012). This is an impractical approach since in the real
scenario of a large-scale radiation accident, the data for
non-irradiated samples from each donor will not be avail-
able and the computing of fold changes will not be possible.
To overcome this problem, in our analysis, we used DCt
values, the approach used previously by Tucker et al. (2012,
2013, 2014). Our results confirmed that this approach is
correct since the cluster analysis based on DCt values of
selected genes has been able to clearly distinguish between
non-irradiated and irradiated samples (Fig. 4). The analysis
was not confused by the time that elapsed since irradiation.
This indicates that even 48 h after irradiation, the biological
dosimetry based on gene expression data may give reliable
results. While our analysis was based on in vitro irradiated
samples and the conclusions drawn might be limited by the
fact that the data from in vitro experiments may not nec-
essarily reflect the conditions of the human body, the data
presented by other authors showed that the results of in vitro
experiments are in good agreement with the in vivo situa-
tion (Amundson et al. 2004; Dressman et al. 2007; Filiano
et al. 2011; Paul et al. 2011).
The potential transcriptional biodosimeters analyzed in
the present study were chosen based on the literature data.
Most of the tested genes were previously shown to be up-
regulated in response to ionizing radiation but some of
them were reported as down-regulated (BCL2, VWCE)
(Boldt et al. 2012; Grace and Blakely 2007). Not all of the
tested genes responded to the ionizing radiation in our
Table 2 Descriptive statistics
of Ct values for the five
potential reference genes from
36 samples obtained in the
experiment (3 donors 9 3
doses 9 4 time points)
Valid N Mean Ct Median Ct Minimum Ct Maximum Ct Variance Std. dev.
ITFG1 Ct 36 29.94 29.92 28.72 31.72 0.51 0.71
DPM1 Ct 36 29.17 29.09 27.87 31.25 0.59 0.77
HPRT1 Ct 36 31.23 30.98 29.71 34.24 0.89 0.95
GAPDH Ct 36 25.40 24.97 23.32 28.99 1.59 1.26
ACTB Ct 36 23.49 23.45 21.66 26.76 1.84 1.35
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experimental setup. This may arise from differences in
starting material, experimental protocols or doses, and
types of radiation. Among radiation-responsive genes, a
significant difference between samples irradiated with
0.6 Gy and 2 Gy was observed only for TNFSF4. For the
other genes, significant differences were observed between
irradiated samples and control samples, but not between
samples irradiated with different doses, even though a
positive correlation between the dose and mRNA level was
observed (Figs. 2, 3). This lack of a sharp difference be-
tween samples irradiated with different doses is reflected in
the cluster analysis, where one of the samples irradiated
with 2 Gy is grouped with 0.6 Gy samples (Fig. 4). This
result is in agreement with the data published by other
Fig. 2 Mean and 0.95
confidence interval of DCt
values for radiation-responsive
genes included in the panel.
a denotes statistically significant
difference in post hoc Tukey’s
test versus mock-irradiated
samples (0 Gy), b denotes
statistically significant
difference in post hoc Tukey’s
test between 0.6 and 2 Gy
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authors, from which it appears that gene expression ana-
lysis performs better in distinguishing between irradiated
and non-irradiated samples than in predicting the actual
absorbed dose (Badie et al. 2013; Filiano et al. 2011; Joiner
et al. 2011; Manning et al. 2013; Riecke et al. 2012; Tucker
et al. 2013, 2014). This leads to the question concerning the
minimal radiation dose necessary to induce gene expres-
sion changes marked enough to allow for the identification
of irradiated blood samples. Our results showed that this
dose is clearly below 0.6 Gy, whereas other authors re-
ported significant changes in gene expression in blood cells
at doses as low as 0.02 Gy (Manning et al. 2013) or even
0.005 Gy (Nosel et al. 2013). Further research is needed to
define the sensitivity of biodosimetry assay based on gene
expression analysis and the minimal absorbed dose that can
be detected.
Fig. 3 Mean and 0.95
confidence interval of DCt
values for genes not included in
the panel. a denotes statistically
significant difference in post
hoc Tukey’s test versus mock-
irradiated samples (0 Gy)
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Table 3 Mean fold changes in
the expression of tested genes in
blood cells after X-irradiation
Mean fold change
0.6 Gy 2 Gy
6 h 12 h 24 h 48 h 6 h 12 h 24 h 48 h
SERPINE1 0.57 0.77 0.75 0.88 1.01 0.71 0.96 0.75
TNFRSF10B 1.71 2.45 2.29 1.85 3.58 3.48 2.89 1.98
VWCE 0.65 1.22 1.11 1.49 0.94 1.30 1.40 2.04
GADD45A 2.61 2.59 3.49 3.20 3.98 4.28 6.61 5.91
CDKN1A 3.49 2.83 1.76 3.61 6.40 5.33 3.41 8.13
MDM2 1.60 1.89 1.81 1.67 1.69 2.22 2.20 2.11
BBC3 5.45 5.92 6.00 3.77 8.57 8.14 8.77 5.27
SESN2 1.42 1.59 1.48 1.17 1.75 1.74 1.69 1.45
BAX 3.37 4.11 4.56 3.78 3.74 5.02 4.96 4.98
DDB2 5.97 5.67 5.22 4.56 7.99 8.62 7.50 6.05
ATF3 1.85 1.13 1.39 1.51 3.17 1.99 1.48 1.19
PLK3 1.52 1.76 1.33 1.59 2.00 2.33 1.80 2.41
GDF15 3.62 2.68 1.41 2.07 12.40 7.21 2.82 4.81
BCL2 1.14 1.16 1.02 0.88 1.48 1.20 0.98 0.82
TNFSF4 4.22 5.08 3.45 3.89 12.49 13.44 10.03 8.09
FDXR 20.71 16.37 10.60 8.95 34.16 29.43 24.05 18.64
Genes for which at least twofold changes in expression were observed for all time points for at least one
dose are given in bold
Fig. 4 Cluster analysis of 36
blood samples based on DCt
values of GADD45A, CDKN1A,
BBC3, BAX, DDB2, GDF15,
TNFSF4, FDXR
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From among the genes significantly up-regulated by ir-
radiation, eight that showed the most pronounced response
were selected for further analysis as a panel potentially
useful for biological dosimetry purposes. Similar panels
were previously tested by other groups and although our
panel composition is unique, significant overlapping with
other panels is apparent (Badie et al. 2013; Boldt et al.
2012; Joiner et al. 2011; Riecke et al. 2012; Tucker et al.
2014). Our results support the idea that a panel of selected
genes may be sufficient for an estimation of the absorbed
radiation dose or, at least, for distinguishing between
samples exposed above or below a given threshold dose.
The latter would be essential in triage after an incident
involving exposure to radiation of a large group of people.
The analysis of a modest group of genes is far more
straightforward and cheaper than the microarray analysis of
a large group of transcripts that was also proposed for
biological dosimetry purposes (Dressman et al. 2007;
Meadows et al. 2008; Paul and Amundson 2008).
Some papers also showed that miRNA level in blood
may be affected by ionizing radiation and that it can be
used for biological dosimetry (Cha et al. 2009; Chaudhry
et al. 2012; Cui et al. 2011; Jacob et al. 2013). This issue
was not addressed in the present paper, but we agree that
change in miRNA expression might be a potentially useful
biodosimetry marker and we plan to perform additional
experiments aiming at validation of such miRNA markers
and including them in our panel.
The level of transcripts used for biodosimetry purposes
may be affected by a variety of confounding factors, such
as infections and inflammatory diseases, cigarette smok-
ing, age, sex, genetic polymorphisms. Experiments on
mice performed by Tucker et al. (2012) showed that
although the expression levels of some genes useful in
biological dosimetry are altered by the bacterial endotoxin
lipopolysaccharide (LPS), the gene expression analysis
may still have utility in biodosimetry even in the presence
of a systemic infection. Similar conclusions were drawn
by Budworth et al. (2012), who employed the model of
human blood irradiated in vitro with the inflammatory
stress mimicked by LPS. Certainly, much more research
on this issue is needed to validate a reliable and accurate
biological dosimeter based on gene expression.
During development of a biological dosimeter based on
transcriptional biomarkers, one must consider the type of
material to be used for the analysis. RNA could be isolated
from the whole blood, total white blood cells (WBC), or
their particular type, as well as from plasma or serum if
circulating miRNA is to be analyzed. In many papers, gene
expression changes after irradiation were analyzed in iso-
lated WBC or lymphocytes (Boldt et al. 2012; Chauhan
et al. 2014; Dressman et al. 2007; Fachin et al. 2007; Joiner
et al. 2011; Kabacik et al. 2011a; Knops et al. 2012;
Meadows et al. 2008; Paul and Amundson 2008; Riecke
et al. 2012). This is reasonable, since in the course of their
development, erythrocytes lose their nuclei which prevents
them from responding to internal and external stimuli by
altering gene transcription and mRNA abundance and
makes them useless for biological dosimetry. However, the
isolation of WBC is possible only from fresh, non-frozen
blood. It could be problematic to perform the isolation
under field conditions and thus it would require transport of
blood samples to the laboratory. During the transport and
handling of non-frozen and non-stabilized blood, gene
expression in cells would be subjected to change, which
could confound the subsequent analysis. Therefore, in the
present paper, we successfully tested a different approach.
RNA for gene expression analysis was extracted from the
whole blood which was frozen immediately after incuba-
tion and stored in -75 C. This approach allows for
preservation of gene expression signature at the moment of
blood collection. The blood can be then stored and trans-
ported in a frozen state to the place where the RNA ex-
traction and gene expression analysis is to be performed.
An alternative approach, probably even more practical in
field conditions, includes the use of different RNA stabi-
lization reagents that are able to immediately lyse all blood
cells and protect RNA from degradation allowing for
sample transport and storage at room temperature for
several hours or even days (Williams 2010).
Taken together, in the present study, we have selected
and tested a new panel of radiation-responsive genes
proving its usefulness for biological dosimetry purposes.
Our results confirm that the analysis of expression of a
carefully selected group of genes can provide sufficient
information to discriminate between irradiated and non-
irradiated blood samples. Further research is needed to
identify the minimal absorbed radiation dose that can be
detected by gene expression analysis and to define the
impact of potential confounding factors on the reliability
of the transcriptional biomarkers-based biological
dosimetry.
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